Binaya Shrestha, MD
Endocrinology, Diabetes & Metabolism Physician · New York, NY
Binaya Shrestha, MD is an endocrinology, diabetes & metabolism physician with a practice address in New York, New York, and NPI 1346343639, issued on Sep 5, 2006. Check the license (New York 239631, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Binaya Shrestha
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- 239631 NY
Self-reported in NPPES; status is on the state search - Practice location
- 3410-3418 Broadway, New York, NY 10031
- Phone
- (212) 283-2099
- Enumerated
- Sep 5, 2006
- Record last updated
- Sep 17, 2008 (not updated in 18 years: call before relying on the address or phone)
- Fax
- (212) 234-2939
- Medicaid ID
- 02093387 NY
- Medicare enrollment
- Enrolled (PECOS I20040510000575); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 970 in New York → Look up another NPI →
Verify Binaya Shrestha in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 239631Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
57% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
4,134 Medicare Part D claims for 366 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 53% of claims.
Most prescribed
- Ozempic399 claims
- Metformin Hcl339 claims
- Levothyroxine Sodium327 claims
- Glipizide324 claims
- Jardiance281 claims
- Farxiga213 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $34.65
1 payment: food and beverage; the largest payer was Medtronic, Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Sjr Medical, PCYonkers, NY
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Binaya Shrestha among 970 endocrinology, diabetes & metabolism physician records in New York
Binaya Shrestha, MD is one of 970 endocrinology, diabetes & metabolism physician records with a practice address in New York. 86% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 9% of them.
- NPI issued2006 · 9% of these records are older, 57% newer
- In a Medicare fileYes · 86% of these records are
- In the CMS Doctors and Clinicians fileYes · 72% of these records are
- Graduated1986 · median 2004 among the 694 with a school on file
- Record last updated2008 · 59% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in New York
There are 970 endocrinology, diabetes & metabolism physician records in New York.
All 970 in New York → Every provider in New York → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Carolyn Becker, M.D.New York, NY 100321457426199
- John Bilezikian, M.D.New York, NY 100321275600975
- Gilbert Brovar, MDNew York, NY 100321952419616
- Adi Cohen, M.D.New York, NY 100321982783080
- Pamela Freda, M.D.New York, NY 100321508933151
- Robin Goland, M.D.New York, NY 100321174549760
- Judy Korner, M.D.New York, NY 100321265509830
- Michelle Lee, M.D.New York, NY 100321821030081
Common questions
What is Binaya Shrestha, MD's NPI number?
Binaya Shrestha, MD's National Provider Identifier (NPI) is 1346343639, issued on Sep 5, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Binaya Shrestha, MD located?
The NPPES record lists a practice address at 3410-3418 Broadway, New York, NY, 10031. Phone: (212) 283-2099. Providers update this record themselves, so call before visiting.
How can I verify Binaya Shrestha, MD's license?
NPPES lists New York license number 239631, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Binaya Shrestha, MD prescribe under Medicare Part D?
In 2024, Binaya Shrestha, MD had 4,134 Medicare Part D claims for 366 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.